journal of men's health
Volume 6, Issue 3 , Pages 162-165 , September 2009

The metabolic syndrome in andrology

  • Roxani Angelopoulou, MD, PhD

      Affiliations

    • Department of Histology and Embryology, National and Kapodistrian University of Athens Medical School, Mikras Asias 75 Goudi, GR 10672, Athens, Greece
    • Corresponding Author InformationCorresponding author.
    • ,
  • Dimitrios G. Goulis, MD, PhD

      Affiliations

    • Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Greece
    • ,
  • Giagkos M. Lavranos, MD

      Affiliations

    • Department of Histology and Embryology, National and Kapodistrian University of Athens Medical School, Mikras Asias 75 Goudi, GR 10672, Athens, Greece

Received 17 February 2009

References 

  1. Mitrakou A. The metabolic syndrome: past, present and future. ANIR: J Hellenic Soc Androl. 2008;10:159–163
  2. Nikopoulou SC, Ilias I. Complications of the metabolic syndrome. ANIR: J Hellenic Soc Androl. 2008;10:171–174
  3. Reaven GM. The insulin resistance syndrome. Curr Atheroscler Rep. 2003;5:364–371
  4. Reaven GM. The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutr. 2006;83:1237–1247
  5. Goulis DG. Metabolic syndrome and testicular dysfunction: definitions and interactions. ANIR: J Hellenic Soc Androl. 2008;10:167–170
  6. Lombardo F, Lupini C, Gandini L, Lenzi A. Infertility and the metabolic syndrome: evaluating patients with diabetes. ANIR: J Hellenic Soc Androl. 2008;10:197
  7. Debono M, Cachia E, Cassar A, Calleja N, Mallia M, Vassallo J. Is erectile dysfunction a sentinel symptom for cardiovascular autonomic neuropathy in patients with type 2 diabetes?. Andrologia. 2008;40(1):1–6
  8. Kyrou I, Tsigos C. Stress, visceral obesity and gonadal function. ANIR: J Hellenic Soc Androl. 2008;10:188–193
  9. Isidori AM, Lenzi A. Androgens and adipose tissue interactions in the metabolic syndrome. ANIR: J Hellenic Soc Androl. 2008;10:179–181
  10. Lavranos G, Angelopoulou R, Manolacou P, Balla M. Hormonal and meta-hormonal determinants of sexual dimorphism. Coll Antropol. 2007;30:659–663
  11. Aversa A, Rossi F, Francomano D, Bruzziches R, Bertone C, Santiemma V, et al. Early endothelial dysfunction as a marker of vasculogenic erectile dysfunction in young habitual cannabis users. Int J Impot Res. 2008;20(6):566–573
  12. Huhtaniemi I, Mäkinen JI, Perheentupa A, Raitakari OT. Late-onset hypogonadism in men. Experience from the Turku Male Ageing Study (TuMAS). Hormones (Athens). 2008;7(1):36–45
  13. Lavranos GM, Angelopoulou R. Actions of sex steroids: implications for the metabolic syndrome. ANIR: J Hellenic Soc Androl. 2008;10:175–178
  14. Koukkou EG. Androgen compounds in clinical andrology. ANIR: J Hellenic Soc Androl. 2008;10:182–187
  15. Jannini EA. Management of metabolic syndrome in the aging male. ANIR: J Hellenic Soc Androl. 2008;10:204
  16. Meinhardt A, Bhushan S, Fijak M, Schuppe H-C. Infection and inflammation in male infertility. ANIR: J Hellenic Soc Androl. 2008;10:164–166
  17. Maccarrone M. Endocannabinoid system, fertilty signals and male reproduction. ANIR: J Hellenic Soc Androl. 2008;10:194–196
  18. Wu FC, Von Eckardstein A. Androgens and coronary artery disease. Endocr Rev. 2003;24:183–217
  19. Gazi IF, Elisaf M. Therapeutic lifestyle changes for people with the metabolic syndrome. ANIR: J Hellenic Soc Androl. 2008;10:198–200
  20. Makrilakis K. Pharmaceutical treatment of diabetes in the metabolic syndrome. ANIR: J Hellenic Soc Androl. 2008;10:201–203
  21. Smyrnis N, Theleritis Chr. Atypical antipsychotics and the metabolic syndrome. ANIR: J Hellenic Soc Androl. 2008;10:205–206

PII: S1875-6867(09)00071-2

doi: 10.1016/j.jomh.2009.05.003

journal of men's health
Volume 6, Issue 3 , Pages 162-165 , September 2009

Article Tools